Searching for your content...
Phone
877-269-7890 from 8 AM - 10 PM ET
Contact Cision
OXFORD, England and SAN ANTONIO, TX, Feb. 25, 2013 /CNW/ - Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the results of a phase II clinical study showing...
OXFORD, England, Oct. 4, 2012 /CNW/ - Circassia Ltd, a specialty biopharmaceutical company focused on allergy, today announced the start of a pivotal phase 3 trial of its investigational ToleroMune®...
Join PR Newswire for Journalists to access all of the free services designated to make your job easier.
In need of subject matter experts for your story? Submit a free ProfNet request and find the sources you need.